Showing 1 - 18 results of 18 for search 'Daniel R. Gomez', query time: 0.08s
Refine Results
-
1
Oligometastatic Disease at Presentation or Recurrence for Nonsmall Cell Lung Cancer by Daniel R. Gomez, Yuzuru Niibe, Joe Y. Chang
Published 2012-01-01
Article -
2
DNA repair capacity correlates with standardized uptake values from 18F-fluorodeoxyglucose positron emission tomography/CT in patients with advanced non–small-cell lung cancer by Xin (Eric) Jiang, Ting Xu, Qingyi Wei, Peng Li, Daniel R. Gomez, Laurence E. Court, Zhongxing Liao
Published 2018-06-01
Article -
3
-
4
The Pulmonary Fibrosis Associated MUC5B Promoter Polymorphism Is Prognostic of the Overall Survival in Patients with Non–Small Cell Lung Cancer (NSCLC) Receiving Definitive Radioth... by Ju Yang, Ting Xu, Daniel R. Gomez, Melenda Jeter, Lawrence B Levy, Yipeng Song, Stephen Hahn, Zhongxing Liao, Xianglin Yuan
Published 2017-04-01
Article -
5
Association Between the Early Discontinuation of Durvalumab and Poor Survival in Patients With Stage III NSCLC by Narek Shaverdian, MD, Michael Offin, MD, Annemarie F. Shepherd, MD, Matthew D. Hellmann, MD, Daniel R. Gomez, MD, Jamie E. Chaft, MD, Andreas Rimner, MD
Published 2021-07-01
Article -
6
Association of lung fluorodeoxyglucose uptake with radiation pneumonitis after concurrent chemoradiation for non-small cell lung cancer by Jinbo Yue, Matthew McKeever, Terence T. Sio, Ting Xu, Jinhai Huo, Qiuling Shi, Quynh-Nhu Nguyen, Ritsuko Komaki, Daniel R. Gomez, Tinsu Pan, Xin Shelley Wang, Zhongxing Liao
Published 2017-06-01
Article -
7
In Vivo Delivery of miR-34a Sensitizes Lung Tumors to Radiation Through RAD51 Regulation by Maria Angelica Cortez, David Valdecanas, Sharareh Niknam, Heidi J Peltier, Lixia Diao, Uma Giri, Ritsuko Komaki, George A Calin, Daniel R Gomez, Joe Y Chang, John Victor Heymach, Andreas G Bader, James William Welsh
Published 2015-01-01
Article -
8
Evaluating single-institution resource costs of consolidative radiotherapy for oligometastatic non-small cell lung cancer using time-driven activity-based costing by Todd A. Pezzi, Matthew S. Ning, Nikhil G. Thaker, David Boyce-Fappiano, Olsi Gjyshi, Nicholas D. Olivieri, Alexis B. Guzman, James R. Incalcaterra, Shane Mesko, Saumil Gandhi, Stephen Chun, Chad Tang, Steven J. Frank, Daniel R. Gomez
Published 2020-07-01
Article -
9
Clinical Outcomes of Dose-Escalated Hypofractionated External Beam Radiation Therapy (5 Gy × 5 Fractions) for Spine Metastasis by Jacob Y. Shin, MD, Noah J. Mathis, BS, Neil Ari Wijetunga, MD, PhD, Divya Yerramilli, MD, Daniel S. Higginson, MD, Adam M. Schmitt, MD, Daniel R. Gomez, MD, Yoshiya J. Yamada, MD, Jonathan T. Yang, MD, PhD
Published 2022-07-01
Article -
10
Prospective Clinical Evaluation of Integrating a Radiation Anatomist for Contouring in Routine Radiation Treatment Planning by Helen Zhang, BS, Ifeanyirochukwu Onochie, MS, Lara Hilal, MD, N. Ari Wijetunga, MD, PhD, Elizabeth Hipp, PhD, David M. Guttmann, MD, Oren Cahlon, MD, Charles Washington, EdD, Daniel R. Gomez, MD, Erin F. Gillespie, MD
Published 2022-11-01
Article -
11
Radiation pneumonitis in lung cancer patients treated with chemoradiation plus durvalumab by Narek Shaverdian, Maria Thor, Annemarie F. Shepherd, Michael D. Offin, Andrew Jackson, Abraham J. Wu, Daphna Y. Gelblum, Ellen D. Yorke, Charles B. Simone II, Jamie E. Chaft, Matthew D. Hellmann, Daniel R. Gomez, Andreas Rimner, Joseph O. Deasy
Published 2020-07-01
Article -
12
Association of cardiac calcium burden with overall survival after radiotherapy for non-small cell lung cancer by Justin M. Haseltine, Aditya Apte, Andrew Jackson, Ellen Yorke, Anthony F. Yu, Andrew Plodkowski, Abraham Wu, Ariel Peleg, Mohammed Al-Sadawi, Michelle Iocolano, Daphna Gelblum, Narek Shaverdian, Charles B. Simone, II, Andreas Rimner, Daniel R. Gomez, Annemarie F. Shepherd, Maria Thor
Published 2023-01-01
Article -
13
Genomic Analyses for Predictors of Response to Chemoradiation in Stage III Non-Small Cell Lung Cancer by Leo Y. Luo, MD, Robert M. Samstein, MD, PhD, Rosalind Dick-Godfrey, Baho Sidiqi, Chunyu Wang, Federica Oro, Mark Sonnick, MD, Paul K. Paik, MD, Jamie E. Chaft, MD, Narek Shaverdian, MD, Daniel R. Gomez, MD, Andreas Rimner, MD, Abraham J. Wu, MD
Published 2021-01-01
Article -
14
Impact of TMB/PD-L1 expression and pneumonitis on chemoradiation and durvalumab response in stage III NSCLC by Joao V. Alessi, Biagio Ricciuti, Xinan Wang, Federica Pecci, Alessandro Di Federico, Giuseppe Lamberti, Arielle Elkrief, Scott J. Rodig, Emily S. Lebow, Jordan E. Eicholz, Maria Thor, Andreas Rimner, Adam J. Schoenfeld, Jamie E. Chaft, Bruce E. Johnson, Daniel R. Gomez, Mark M. Awad, Narek Shaverdian
Published 2023-07-01
Article -
15
Multi-institutional analysis of aneuploidy and outcomes to chemoradiation and durvalumab in stage III non-small cell lung cancer by Biagio Ricciuti, Joao V Alessi, Mark M Awad, Arielle Elkrief, Jamie E Chaft, Bruce E Johnson, Xinan Wang, Allison L Richards, Federica Pecci, Alessandro Di Federico, Adam J Schoenfeld, Malini M Gandhi, Adam Price, Emily S Lebow, Patricia Mae G Santos, Maria Thor, Andreas Rimner, Daniel R Gomez, Narek Shaverdian
Published 2023-11-01
Article -
16
Phase I Trial of Definitive Concurrent Chemoradiotherapy and Trametinib for KRAS-Mutated Non-Small Cell Lung Cancer by Steven H Lin, Heather Y Lin, Vivek Verma, Meng Xu-Welliver, Peter F Thall, Luyang Yao, Peter Y Kim, Dan S Gombos, Jitesh D Kawedia, Ritsuko Komaki, Daniel R Gomez, Quynh-Nhu Nguyen, Michael S O'Reilly, Charles Lu, Frank V Fossella, Ferdinandos Skoulidis, Jianjun Zhang, Anne S Tsao, John V Heymach, George R Blumenschein
Published 2022-01-01
Article -
17
Surgical Complexity of Pulmonary Resections Performed for Oligometastatic NSCLC by Mara B. Antonoff, MD, Hope A. Feldman, MD, Kyle G. Mitchell, MD, Ahsan Farooqi, MD, Ethan B. Ludmir, MD, Wayne L. Hofstetter, MD, Reza J. Mehran, MD, Ravi Rajaram, MD, David C. Rice, MB, BCh, Boris Sepesi, MD, Stephen G. Swisher, MD, Garrett L. Walsh, MD, Saumil Gandhi, MD, PhD, Daniel R. Gomez, MD, Ara A. Vaporciyan, MD
Published 2022-03-01
Article -
18
ctDNA-based detection of molecular residual disease in stage I-III non-small cell lung cancer patients treated with definitive radiotherapy by Emily S. Lebow, Emily S. Lebow, Narek Shaverdian, Jordan E. Eichholz, Leah B. Kratochvil, Megan McCune, Yonina R. Murciano-Goroff, Yonina R. Murciano-Goroff, Justin Jee, Justin Jee, Juliana Eng, Juliana Eng, Jamie E. Chaft, Mark G. Kris, Mark G. Kris, Ekaterina Kalashnikova, Jordan Feeney, Carly Bess Scalise, Sumedha Sudhaman, Charuta C. Palsuledesai, Meenakshi Malhotra, Michael Krainock, Himanshu Sethi, Alexey Aleshin, Minetta C. Liu, Annemarie F. Shepherd, Abraham J. Wu, Charles B. Simone, Daphna Y. Gelblum, Kaylie A. Johnson, Charles M. Rudin, Charles M. Rudin, Daniel R. Gomez, Pedram Razavi, Pedram Razavi, Jorge S. Reis-Filho, James M. Isbell, James M. Isbell, Bob T. Li, Bob T. Li, Andreas Rimner
Published 2023-09-01
Article